Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis

Kalincik T., Jokubaitis V., IZQUIERDO G., DUQUETTE P., GIRARD M., Grammond P., ...Daha Fazla

MULTIPLE SCLEROSIS JOURNAL, cilt.21, sa.9, ss.1159-1171, 2015 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 21 Sayı: 9
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1177/1352458514559865
  • Dergi Adı: MULTIPLE SCLEROSIS JOURNAL
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1159-1171
  • Anahtar Kelimeler: Multiple sclerosis, treatment outcomes, patient registry, real-world date, propensity score, relapses, disability, MULTICENTER, REBIF, BIAS
  • Karadeniz Teknik Üniversitesi Adresli: Evet

Özet

Background: The results of head-to-head comparisons of injectable immunomodulators (interferon , glatiramer acetate) have been inconclusive and a comprehensive analysis of their effectiveness is needed.